Bill
Bill > SF120
MN SF120
MN SF120Cost sharing limitation for prescription drugs and related medical supplies prescribed to treat a chronic disease
summary
Introduced
01/10/2023
01/10/2023
In Committee
03/22/2023
03/22/2023
Crossed Over
Passed
Dead
05/20/2024
05/20/2024
Introduced Session
93rd Legislature 2023-2024
Bill Summary
A bill for an act relating to insurance; limiting co-payments for prescription drugs and related medical supplies prescribed to treat a chronic disease; amending Minnesota Statutes 2022, sections 256B.0631, subdivision 1; 256L.03, subdivision 5; proposing coding for new law in Minnesota Statutes, chapter 62Q.
AI Summary
This bill limits the cost-sharing (co-payments and coinsurance) for prescription drugs and related medical supplies prescribed to treat chronic diseases, such as diabetes, asthma, and allergies requiring epinephrine auto-injectors. The bill sets a maximum of $25 per one-month supply for each prescription drug and $50 per month for all related medical supplies, regardless of the amount or type of medication or supplies required. The cost-sharing limits apply to health plans offered, issued, or renewed on or after January 1, 2024, and also apply to Medical Assistance (Medicaid) and MinnesotaCare programs. The bill ensures that these cost-sharing limits do not result in ineligibility for health savings accounts or catastrophic health plans.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (2)
Last Action
Comm report: To pass and re-referred to Health and Human Services (on 03/22/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...